Published in Blood Weekly, April 25th, 2002
Dr. Ivone B. Otazu and colleagues at the National Cancer Institute in Rio de Janeiro and the Federal University of Rio de Janeiro examined the utility of BCR-ABL measurement after bone marrow transplantation.
Quantitative PCR was highly useful for detecting minimal residual disease in the form of BCR-ABL transcripts, Otazu and coauthors found.
They measured levels of the oncogene in a total of 39 CML...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.